Harrison Gunn

ID: 1b83cf65-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Ranibizumab Updates: FDA approval of Roche’s Refillable Ocular Implant and FDA Acceptance of Bioeq’s BQ201 BLA

Big Molecule Watch · November 8, 2021

FDA Accepts BeiGene’s BLA for Tislelizumab in Esophageal Squamous Cell Carcinoma

Big Molecule Watch · September 28, 2021

American Academy of Ophthalmology Pushes Back Against Bevacizumab Biosimilar Use in Treating Ophthalmic Conditions

Big Molecule Watch · August 19, 2021

Patient Advocacy Groups Submit Letter in Support of BIOSIM Act

Big Molecule Watch · July 9, 2021

Study Concludes Two Adalimumab Biosimilars may be as Safe and Effective as Originator

Big Molecule Watch · May 28, 2021